To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients.
Epistemonikos ID: ee045b5c9c7e90278565f0aec3bc065ca8d75e19
First added on: May 12, 2024